Giovannie Isaac-Coss, MD
@IBD_docGio
Followers
294
Following
693
Media
25
Statuses
93
IBD Fellowship @RushMedical ✳️ | Aspiring Gastroenterologist | NYC Residency-Trained | Proud @UPR_oficial Alum 🇵🇷🇺🇸| Passionate About Gut Health & IBD 🧬
Chicago, IL
Joined July 2024
Excited to be at #ACG2025! 🙌 ✅ 9 First-Author Posters ✅ 6 Co-Author Posters 🏅 3 ACG Presidential Poster Awards 🏆 Grateful to share our work and reconnect with incredible friends & mentors 💙 #GITwitter @Rush_GI @AmCollegeGastro #IBD
3
2
48
PreB2B #IBDPoll1️⃣ 22 New dx of ileocolonic CD, now w N/V, abdo pain. CTscan report a distal ileal stricture: thickened bowel wall, narrowed lumen, at 10 cm above the ICV. ✂️What factor is a high predictor of needing surgery in the near future?
1
5
7
Rising PGY-2 GI 🌟 @Dr_M_Kakarla
#ACG2025 wrap-up 🌵🏜️ Grateful for 18 acceptances & 7 presentations reflecting collaboration, mentorship & purpose that involved 6-12 months of work, re-analysis & revisions. Some evolved into full manuscripts, others led to new questions, and a few paused due to limited scope.
0
1
10
Last day at #ACG2025 ✅ Had an amazing time learning, presenting, and connecting with incredible colleagues and mentors. Until next time, Phoenix! 🌵🏅 @NancyReau @LodhiMaham @RushMedical
0
2
41
Honored to share that 3 of my 9 abstracts were selected as Presidential Poster Award recipients 🏅 at #ACG2025 in Phoenix 🎉 Out of nearly 6,000 submissions, only ~5% receive this distinction. Grateful to my mentors at @Rush_GI for their guidance 🙏 #GITwitter #IBDresearch
6
4
56
Recall #ExtraintestinalManifestations (EIMs) that parallel IBD activity?🤷🏻♀️ @IBD_Afzali shares her “Rule of E” ▶️ Starts w/“E” = parallels IBD activity 🔹Episcleritis 🔹E. nodosum 🔹Elbows (peripheral lg joints) ▶️ Does not start w/“E” = not parallel 🔹Uveitis 🔹Pyoderma
2
3
9
Looking forward to the special IBD #VirtualGrandRounds with @IBD_Afzali @IBDMD @SunandaKaneMD @JPAchkarMD @AmCollegeGastro 🧬💡
Join ACG and colleagues for a special IBD Circle #VirtualGrandRounds! Bringing Latest ACG Guidelines to Life: Practical, Case-Based Insights for IBD Care Wednesday, August 20 at 8:00pm ET Register: https://t.co/yRsHiWYaXL
@IBD_Afzali @IBDMD @SunandaKaneMD @JPAchkarMD
0
2
8
📢🩺 Sharing my new publication in the @ACGCRJ: “First Reported Successful Use of Infliximab Maintenance Therapy for Dual Treatment of Crohn’s Disease & Idiopathic Retroperitoneal Fibrosis” Link 👉🏼 https://t.co/P4BWghZhZ4 🔑 Key Findings: 💉 First documented case using infliximab
journals.lww.com
peritoneal fibrosis diagnosis. Given shared inflammatory pathways, he was treated with prednisone followed by infliximab. Post-treatment imaging showed mass reduction and hydronephrosis improvement....
1
5
13
Check out my latest publication! 🔥 • Appendectomy is associated with 68% lower odds of Ulcerative Colitis🧬 • But 16% higher odds of Crohn’s Disease🧬 • Women show the strongest shifts 👩⚕️ This adds to the emerging body of evidence that the appendix might modulate IBD odds.
journals.sagepub.com
This study investigates the gender-specific and demographic associations of appendectomy on the concurrent diagnosis of inflammatory bowel disease (IBD), using ...
0
4
8
On my days off, I review IBD-related submissions for the @ACGCRJ 📄☕️ Grateful for the opportunity—I’ve been learning so much from these unique and challenging cases. #IBD #GITwitter @AmCollegeGastro
0
0
7
Time to rethink microscopic colitis? New study finds NO causative association between NSAIDs, PPIs, statins, or ACE inhibitors with microscopic colitis. 💊 #MedTwitter #GITwitter #IBD
https://t.co/3ym9Py5uZk
5
40
115
Always excited to share good news that highlights our team’s efforts — our abstracts were accepted to #ACG2025! Grateful to my amazing co-authors and mentors for their support. @ShreyakSharma @AlexLevyMD We’re headed to Phoenix! 🌵☀️ @AmCollegeGastro @YaleDigestive
4
2
59
🔥 16 abstracts accepted for #ACG2025 — including 9 as first author 🧬 Grateful for the opportunity to present research advancing care in inflammatory bowel diseases 🤝 Looking forward to connecting with GI program directors, colleagues, and collaborators 📍 See you in Phoenix!
2
1
54
@IBD_docGio @YaleDigestive @dgoyesv @AlexLevyMD @JillGaidosMD @CrohnsColitisFn @CrohnsEffect @getgutsycanada @YaleMed Top-down can lead to deep remission early on — especially when poor prognostic factors are in play 💥 That said, step-up still makes sense for mild Crohn’s with close monitoring and timely escalation 🔄 One size doesn’t fit all! 🧢 Saludos 🇵🇷 @IBD_docGio ✌🏽
1
1
1
🔹 Start biologics early for mod-severe CD—don’t wait for failure of other meds. 🔹 Anti-TNF, IL-23, & JAKi (TNF experienced pt) are effective options for induction. 🔹 🧪 Use fecal calprotectin & MRE to monitor disease activity non-invasively.
🚨 New ACG Crohn’s Guidelines (2025) ▪️Scope at 6–12 mo post-op ▪️Early advanced therapy = key ▪️Anti-TNF, IL-23, JAKi > mesalamine ▪️High-risk = smoking, prior surgery, penetrating dz ▪️Surgery for abscess >2cm or strictures 🔗 https://t.co/PfEj2Rvnke
0
3
7
🔬 Presented my IBD research at the @Rush_GI Fellowship Research Symposium! 🎤 🧠 Shared the podium with my Rush GI co-fellows—inspirational work all around! 🙏 Grateful for the continued guidance and support from our mentors #RushGI #IBDFellowship #GITwitter @RushMedical
2
3
18
Check out this interesting case report written up by our IBD fellow @IBD_docGio and 3rd year fellow @ZoePostMD! 🚨📄
cureus.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms and significant non-motor complications, including gastrointestinal disturbances. Constipatio...
0
1
4
On #WorldIBDDay, I’m highlighting my work on the impact of mental health in ulcerative colitis hospitalizations: 🧠 Depression worsen hospitalization outcomes 📈 Increase length of stay 💸 Raise hospitalization costs ⭐️Mental health must be part of IBD care. #GITwitter
4
5
27